Regenxbio (RGNX) EBITDA Margin (2015 - 2026)
Regenxbio (RGNX) reported EBITDA Margin of 30.57% for Q2 2026, up 308.55 percentage points from -277.98% a year earlier and up 1274.19 percentage points from the prior quarter.
Powered by 
Analysis
Regenxbio (RGNX) EBITDA Margin (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Regenxbio's EBITDA Margin came in at -85.27%, up 10.22 percentage points year-over-year; for FY2025, it was -85.42%, up 175.16 percentage points from FY2024.
- EBITDA Margin has a five-year change of -13.71 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at -260.57% in FY2024 (+17.35 pp), -277.93% in FY2023 (-56.18 pp), -221.75% in FY2022 (-257.81 pp) and 36.05% in FY2021 (+107.76 pp).
- The Q2 2026 figure ranks as the highest quarterly EBITDA Margin since Q4 2021.
- Year over year, EBITDA Margin gained in five of the last eight quarters, with an average year-over-year change of -57.57 percentage points.
- The high point for year-over-year EBITDA Margin in five years was Q1 2025 (a gain of 400.11 percentage points); the low point was Q1 2026 (a drop of 1261.69 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -1243.63% (Q1 2026), -177.23% (Q4 2025) and -163.20% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 54.65% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 40.75% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 42.49% |
| 10 | Regenxbio | 418.33 Mn | -341.95 Mn | - | 30.57% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.57% |
| Mar 31, 2026 | -1,243.63% |
| Dec 31, 2025 | -177.23% |
| Sep 30, 2025 | -163.20% |
| Jun 30, 2025 | -277.98% |
| Mar 31, 2025 | 18.07% |
| Dec 31, 2024 | -223.18% |
| Sep 30, 2024 | -240.18% |
| Jun 30, 2024 | -233.17% |
| Mar 31, 2024 | -382.04% |
| Dec 31, 2023 | -268.17% |
| Sep 30, 2023 | -209.55% |
| Jun 30, 2023 | -343.76% |
| Mar 31, 2023 | -323.85% |
| Dec 31, 2022 | -171.14% |
| Sep 30, 2022 | -254.59% |
| Jun 30, 2022 | -183.44% |
| Mar 31, 2022 | -310.27% |
| Dec 31, 2021 | 79.33% |
| Sep 30, 2021 | -177.17% |
API Access
Regenxbio EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();